scholarly journals The interplay between emotion regulation, emotional well‐being, and cognitive functioning in brain tumor patients and their caregivers: An exploratory study

2019 ◽  
Vol 28 (10) ◽  
pp. 2068-2075
Author(s):  
Hannelore Aerts ◽  
Tineke Van Vrekhem ◽  
Lara Stas ◽  
Daniele Marinazzo
2019 ◽  
Author(s):  
Hannelore Aerts ◽  
Tineke Van Vrekhem ◽  
Lara Stas ◽  
Daniele Marinazzo

Objective: Brain tumor patients may suffer from a range of health-impairing problems reducing their quality of life. To identify potential targets for interventions, we examined the influence of different emotion regulation strategies on emotional well-being and cognitive functioning as indices of quality of life in patients and their caregivers in the early phase of treatment. Methods: To this end, we conducted a longitudinal study, measuring emotion regulation, emotional well-being and cognitive functioning on the day before each patient’s tumor resection (28 patients and 11 caregivers) and several months after neurosurgery (22 patients and 10 caregivers).Results: Results showed emotion regulation strategies are relatively stable from pre- to post-operative assessment. Nevertheless, several associations between emotion regulation strategies and quality of life indices were evident after tumor resection. In particular, our results were largely in line with previous research findings in healthy and other patient populations, corroborating the adaptive character of cognitive reappraisal, whereas suppression and expression of emotions were related to reduced cognitive and affective functioning, respectively.Conclusions: Based on these results, we suggest that further intervention or qualitative studies explore whether therapeutic interventions directed towards mastery of cognitive reappraisal techniques and appropriate expression of emotions could lead to improved long-term adjustment among brain tumor patients and their caregivers.


2006 ◽  
Vol 24 (9) ◽  
pp. 1415-1420 ◽  
Author(s):  
Edward G. Shaw ◽  
Robin Rosdhal ◽  
Ralph B. D'Agostino ◽  
James Lovato ◽  
Michelle J. Naughton ◽  
...  

Purpose A prospective, open-label phase II study was conducted to determine whether donepezil, a US Food and Drug Administration–approved reversible acetylcholinesterase inhibitor used to treat mild to moderate Alzheimer’s type dementia, improved cognitive functioning, mood, and quality of life (QOL) in irradiated brain tumor patients. Patients and Methods Thirty-four patients received donepezil 5 mg/d for 6 weeks, then 10 mg/d for 18 weeks, followed by a washout period of 6 weeks off drug. Outcomes were assessed at baseline, 12, 24 (end of treatment), and 30 weeks (end of wash-out). All tests were administered by a trained research nurse. Results Of 35 patients who initiated the study, 24 patients (mean age, 45 years) remained on study for 24 weeks and completed all outcome assessments. All 24 patients had a primary brain tumor, mostly low-grade glioma. Scores significantly improved between baseline (pretreatment) and week 24 on measures of attention/concentration, verbal memory, and figural memory and a trend for verbal fluency (all P < .05). Confused mood also improved from baseline to 24 weeks (P = .004), with a trend for fatigue and anger (all P < .05). Health-related QOL improved significantly from baseline to 24 weeks, particularly, for brain specific concerns with a trend for improvement in emotional and social functioning (all P < .05). Conclusion Cognitive functioning, mood, and health-related QOL were significantly improved following a 24-week course of the acetylcholinesterase inhibitor donepezil. Toxicities were minimal. We are planning a double blinded, placebo-controlled, phase III trial of donepezil to confirm these favorable results.


2020 ◽  
Author(s):  
Isabel K Gosselt ◽  
Vera P M Scheepers ◽  
Lauriane A Spreij ◽  
Johanna M A Visser-Meily ◽  
Tanja C W Nijboer

Abstract Background Cognitive deficits have been frequently assessed in brain tumor patients. However, self-reported cognitive complaints received little attention so far. Cognitive complaints are important as they often interfere with participation in society. In this study, cognitive complaints were systematically assessed in brain tumor patients. As patients’ experiences and relatives’ estimations may vary, the level of agreement was investigated. Methods Brain tumor outpatients (n=47) and relatives (n=42) completed the inventory Cognitive Complaints - Participation, assessing cognitive complaints across ten daily life activities and cognitive domains (total, memory, executive, attention). Cognitive complaints scores were compared between patients with different clinical characteristics (tumor type, number of treatments, absence/presence of epilepsy). Complaints difference scores in patient-relative pairs were calculated to explore the level of agreement using interrater agreements (ICC). Furthermore, we explored whether the level of agreement was related to (1) the magnitude of cognitive complaints in patient-relative pairs and (2) patients’ cognitive functioning (assessed with the Montreal Cognitive Assessment). Results Patients and relatives reported most cognitive complaints during work/education (100%) and social contacts (88.1%). Patients with different clinical characteristics reported comparable cognitive complaints scores. Overall, the level of agreement in patient-relative pairs was moderate-good (ICC 0.73–0.86). Although in 24% of the pairs there was a substantial disagreement. The level of agreement was not related to the magnitude of complaints in patient-relative pairs or patients’ cognitive functioning. Conclusion Both the perspectives of brain tumor patients and their relatives’ on cognitive complaints are important. Clinicians could encourage communication to reach mutual understanding.


2019 ◽  
Vol 21 (Supplement_3) ◽  
pp. iii8-iii9
Author(s):  
M Renovanz ◽  
J Coburger ◽  
G Tabatabai ◽  
F Ringel ◽  
C Wirtz ◽  
...  

Abstract BACKGROUND Patient-centered assessments and disease-adjusted patient-reported outcome measures (PROMs) are crucial in neuro-oncology. The Distress Thermometer (DT) is a well-accepted screening tool for cancer patients including a numerical rating scale (1–10, cut-offs indicating relevant distress ≥4–6) and 40 items describing possible problem categories (emotional, social, physical, practical and spiritual). The aims of the first part of the “Adaption of the Distress Thermometer in patients with intracranial tumors” (HEAT) study were to evaluate the importance and relevance of items for brain tumor patients (BTP). MATERIAL AND METHODS The multicenter study included three University hospitals. After given informed consent patients were prospectively evaluated either during their hospital stay or in the outpatient setting using DT as well as the 40 item problem list. Clinical and demographic data were recorded. We performed an analysis regarding frequency of indicated topics and evaluated their relevance for patients’ psychosocial well-beings via Pearson correlations with the DT score. RESULTS Data of n = 670 patients were analyzed. Mean age was 52 years (SD = 14, range 18–81), most of the patients harbored WHO°I tumors (37%) and WHO°IV tumors (28%). Male to female ratio was 1:1, 17% were assessed preoperatively, 40% postoperatively and 43% during adjuvant therapy or follow-up. 14% of the patients faced a tumor recurrence at assessment. Mean score of DT was 5.23 (SD = 2.9, range 0–10). Applying a cut-off score ≥ 4, 61% reported distress (≥ 5: 46% and ≥ 6: 37%). Regarding the relevance of the problem list for BTP, emotional problems (e. g., anxiety, depression) were most frequently reported. A total of 14/40 (35 %) of items were endorsed by less than 10% of patients. With exception of emotional problems all areas were reflected: practical problems (e. g., problems with child care or insurance), social problems (e. g., problems with children), spiritual concerns (e. g., loss of faith), and physical problems (e. g., breathing, fever). However, some of these rarely reported problems were of relevance for patients’ psychosocial well-being as indicated by significant correlations between the respective item and the DT score. This was, for example, the case for problems with childcare (r = .106; p < .01) or breathing (r = .125; p = .001). CONCLUSION Tools developed for cancer patients do not yet perfectly reflect all needs of BTP. Based on our data, we suggest further adjustments of available tools. Yet, it should be taken into account that subgroups of BTP may require different problem lists in the DT, as we observed some topics (e.g. breathing) probably be related to BTP under chemotherapy or steroids only. Moreover, our data require cross-cultural validation as especially results regarding practical problems and insurance might differ in cultures with different social security systems.


2021 ◽  
Author(s):  
Dina M Randazzo ◽  
Frances McSherry ◽  
James E Herndon ◽  
Mary L Affronti ◽  
Eric S Lipp ◽  
...  

Abstract Background Spirituality can impact patients’ attitudes and decisions about treatment and end-of-life care when coping with cancer. Previous studies documented health-related quality of life (HRQoL) and spiritual well-being (SWB) as positively correlated within a general cancer patient population, but little is known about their association in the primary brain tumor population. We sought to measure SWB in primary brain tumor patients and evaluate whether it was associated with HRQoL. Methods Six-hundred and six patients treated at The Preston Robert Tisch Brain Tumor Center at Duke between December 16, 2013 and February 28, 2014 with data in the PRoGREss registry are included in this retrospective analysis. Each patient completed the Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being 12 (FACIT-Sp-12) and -Fatigue (FACIT-F), and the Functional Assessment of Cancer Therapy-General and -Brain (FACT-G and FACT-Br). Results Mean age was 49.1 years (SD = 13.5 years), male (N = 328, 54.1%), married (N = 404, 66.7%), at least college-educated (N = 381, 62.9%), and diagnosed with a high-grade glioma (N = 412, 68.0%). Multiple regression analyses were performed on both the FACT-G and the FACT-Br using the FACIT-Sp-12 sub-scales of Meaning/Peace and Faith, FACIT-F, belief in God or a higher power, prayer, gender, tumor grade, and Karnofsky Performance Status (KPS) as predictors. We found that greater SWB (measured by FACIT-Sp-12) was associated with better HRQoL (measured by FACT-G and FACT-Br; p &lt; .0001). Conclusion The association between reported SWB and reported improved HRQoL emphasizes the importance of spirituality in primary brain tumor patients, suggesting SWB must be considered in strategies to improve HRQoL.


2014 ◽  
Vol 16 (suppl 5) ◽  
pp. v182-v183
Author(s):  
D. Randazzo ◽  
M. Affronti ◽  
E. Lipp ◽  
F. McSherry ◽  
J. Herndon ◽  
...  

Cancers ◽  
2021 ◽  
Vol 13 (6) ◽  
pp. 1276
Author(s):  
Fabian M. Troschel ◽  
Franziska Ahndorf ◽  
Lisa-Marie Wille ◽  
Ralf Brandt ◽  
Johanna Jost ◽  
...  

The COVID-19 pandemic is associated with significant morbidity, mortality, and restrictions on everyday life worldwide. This may be especially challenging for brain tumor patients given increased vulnerability due to their pre-existing condition. Here, we aimed to investigate the quality of life (QoL) in brain tumor patients and relatives in this setting. Over twelve weeks during the first wave of the pandemic (04–07/2020), brain tumor patients and their families from two large German tertiary care centers were asked to complete weekly questionnaires for anxiety, depression, distress, and well-being. Information regarding social support and living conditions was also collected. One hundred participants (63 patients, 37 relatives) completed 729 questionnaires over the course of the study. Compared to relatives, patients showed more depressive symptoms (p < 0.001) and reduced well-being (p = 0.013). While acceptance of lockdown measures decreased over time, QoL remained stable. QoL measures between patients and their families were weakly or moderately correlated. The number of social contacts was strongly associated with QoL. Age, living conditions, ongoing therapy, employment, and physical activity were other predictors. QoL is correlated between patients and their families and heavily depends on social support factors, indicating the need to focus on the entire family and their social situation for QoL interventions during the pandemic.


Sign in / Sign up

Export Citation Format

Share Document